1.Annual review of basic research on lung transplantation of China in 2024
Jier MA ; Junmin ZHU ; Lan ZHANG ; Xiaohan JIN ; Xiangyun ZHENG ; Senlin HOU ; Zengwei YU ; Yaling LIU ; Haoji YAN ; Dong TIAN
Organ Transplantation 2025;16(3):386-393
Lung transplantation is the optimal treatment for end-stage lung diseases and can significantly improve prognosis of the patients. However, postoperative complications such as infection, rejection, ischemia-reperfusion injury, and other challenges (like shortage of donor lungs) , limit the practical application of lung transplantation in clinical practice. Chinese research teams have been making continuous efforts and have achieved breakthroughs in basic research on lung transplantation by integrating emerging technologies and cutting-edge achievements from interdisciplinary fields, which has strongly propelled the development of this field. This article will comprehensively review the academic progress made by Chinese research teams in the field of lung transplantation in 2024, with a focus on the achievements of Chinese teams in basic research on lung transplantation. It aims to provide innovative ideas and strategies for key issues in the basic field of lung transplantation and to help China's lung transplantation cause reach a higher level.
2.Role of telomerase in the onset and treatment of gastric cancer.
Gang CHEN ; Minmin ZHANG ; Yulu WANG ; Yumin LI ; Junmin ZHU
Journal of Central South University(Medical Sciences) 2025;50(2):259-265
China is a high-incidence region for gastric cancer globally. The disease is characterized by a high morbidity rate, low early diagnostic rate, and poor long-term outcomes, imposing a significant burden on both patients and society. Therefore, exploring the pathogenesis of gastric cancer, developing novel therapeutic strategies, and identifying new drug targets is of great importance. Telomerase expression is broadly associated with cancer cell targeting, and its up-regulation is one of the key factors driving the initiation and progression of gastric cancer. Additionally, telomerase is intricately involved in the regulation of autophagy and autophagy-associated cell death. While autophagy can induce chemoresistance, excessive autophagy may lead to cell death, which also constitutes one of the mechanisms of chemotherapy. Telomerase not only directly contributes to gastric cancer pathogenesis but also indirectly influences its development and treatment by modulating autophagy and autophagic cell death. Therefore, telomerase holds promise as a novel therapeutic target in gastric cancer.
Humans
;
Stomach Neoplasms/genetics*
;
Telomerase/genetics*
;
Autophagy/physiology*
3.Mechanism of telomerase in affecting biological characteristics of gastric cancer
Yulu WANG ; Junmin ZHU ; Zhiyao HAN ; Senhuan WANG ; Youxi JIANG ; Minmin ZHANG ; Gang CHEN
International Journal of Surgery 2024;51(1):66-72
Gastric cancer is one of the major diseases threatening human health, with a high incidence and a low early diagnostic rate. There are many bottlenecks encountered during its treatment. Consequently, improving the early diagnostic rate and exploring new therapeutic targets are currently urgent challenges that need to be addressed. Telomerase is undetectable in normal tissues, but it exhibits high specificity and sensitivity in most cancers and has a definite correlation with prognosis. It may serve as a serum tumor marker and prognostic indicator. Human telomerase reverse transcriptase (hTERT) gene polymorphism can regulate the susceptibility of people to gastric cancer, and affect the occurrence, development, proliferation and apoptosis of gastric cancer through its target gene. Substances such as resistin, visfatin, G-quadruplex and methylenedioxyaniline can affect the occurrence and development of gastric cancer by regulating telomerase expression. The mechanism by which hTERT regulates tumor invasion and metastasis is currently unclear, so elucidating its mechanism is of great significance.This paper will review the research progress of this mechanism in recent years.
4.Neoadjuvant sintilimab and apatinib combined with perioperative FLOT chemotherapy for locally advanced gastric cancer: A prospective, single-arm, phase II study.
Huinian ZHOU ; Bo LONG ; Zeyuan YU ; Junmin ZHU ; Hanteng YANG ; Changjiang LUO ; Wenjuan ZHANG ; Chi DONG ; Xiaoying GUAN ; Long LI ; Gengyuan ZHANG ; Hongtai CAO ; Shigong CHEN ; Linyan ZHOU ; Qichen HE ; Shiying GAN ; Xiangyan JIANG ; Qianlin GU ; Keshen WANG ; Wengui SHI ; Long QIN ; Zuoyi JIAO
Chinese Medical Journal 2024;137(21):2615-2617
5.Tumor cell membrane-coated continuous electrochemical sensor for GLUT1 inhibitor screening
Jiaqian ZHAO ; Yuqiao LIU ; Ling ZHU ; Junmin LI ; Yanhui LIU ; Jiarui LUO ; Tian XIE ; Dajing CHEN
Journal of Pharmaceutical Analysis 2023;13(6):673-682
Glucose transporter 1(GLUT1)overexpression in tumor cells is a potential target for drug therapy,but few studies have reported screening GLUT1 inhibitors from natural or synthetic compounds.With cur-rent analysis techniques,it is difficult to accurately monitor the GLUT1 inhibitory effect of drug molecules in real-time.We developed a cell membrane-based glucose sensor(CMGS)that integrated a hydrogel electrode with tumor cell membranes to monitor GLUT1 transmembrane transport and screen for GLUT1 inhibitors in traditional Chinese medicines(TCMs).CMGS is compatible with cell membranes of various origins,including different types of tumors and cell lines with GLUT1 expression knocked down by small interfering RNA or small molecules.Based on CMGS continuous monitoring technique,we inves-tigated the glucose transport kinetics of cell membranes with varying levels of GLUT1 expression.We used CMGS to determine the GLUT1-inhibitory effects of drug monomers with similar structures from Scutellaria baicalensis and catechins families.Results were consistent with those of the cellular glucose uptake test and molecular-docking simulation.CMGS could accurately screen drug molecules in TCMs that inhibit GLUT1,providing a new strategy for studying transmembrane protein-receptor interactions.
6.Medical nutrition therapy of coronavirus disease 2019 inpatients based on the tenth edition of the National Diagnosis and Treatment Protocol
Mingwei ZHU ; Lili DING ; Liru CHEN ; Hongyuan CUI ; Junmin WEI
Chinese Journal of Clinical Nutrition 2023;31(1):54-57
Most hospitalized patients infected with coronavirus disease 2019 (COVID-19) are in severe or critical condition, and malnutrition is a key factor contributing to adverse outcomes. The basic principles of medical nutrition therapy have been determined in the recently released tenth edition of the National Diagnosis and Treatment Protocol. The principles have promoted nutritional risk assessment, emphasized the preferred method of enteral nutrition, and recommended the daily intake of calories at 25 to 30 kcal/kg and protein at > 1.2g/kg. Parenteral nutrition should be also added when necessary. Based on the above principles, Beijing Hospital has refined the medical nutrition therapy measures to facilitate the implementation in clinical practice, in order to improve healthcare quality and decrease the mortality in COVID-19 patients.
7.Research progress on ultrasound assessment of sarcopenia
Boyue JIANG ; Meilan LIU ; Jie MA ; Qing WANG ; Hongyuan CUI ; Mingwei ZHU ; Junmin WEI
Chinese Journal of Clinical Nutrition 2023;31(1):58-62
Sarcopenia is an age-related syndrome with progressive, generalized loss of muscle mass, strength, and physiological function. Low muscle mass is an important diagnostic criterion for sarcopenia. Ultrasound is safe, convenient and cost-effective, with extensive availability. It's a promising diagnostic tool for muscle mass assessment and sarcopenia screening in the elderly population. This review focuses on the specific methods and latest research progress on ultrasound assessment of sarcopenia.
8.Research progression in the mechanism of upper gastrointestinal hemorrhage in decompensated liver cirrhosis
Minmin ZHANG ; Gang CHEN ; Junmin ZHU ; Bin ZHAO ; Lijuan LIANG
International Journal of Surgery 2021;48(1):50-54
Liver cirrhosis in China can be caused by many causes of which the most important one is chronic viral hepatitis. Hemorrhage and ascites were the main manifestations of decompensated liver cirrhosis, and the main cause of hemorrhage is viral hepatitis. The pathological basis of hemorrhage is portal hypertension and its secondary pathophysiological changes. Additionally, the deficiency of coagulation factors and the imbalance of coagulation and fibrinolysis both of which caused by the hypofunction of liver are also important reasons. This article reviews the mechanism of hemorrhage in decompensated liver cirrhosis in order to provide help for further research.
9.Research progression in the application of radiotherapy in the comprehensive treatment of diffuse gastric cancer
Gang CHEN ; Minmin ZHANG ; Junmin ZHU ; Yumin LI
International Journal of Surgery 2021;48(2):123-128
The incidence of diffuse gastric cancer is increasing year by year, comprehensive therapy is the main treatment. The main reason of surgical treatment failure is local recurrence, and the long-term curative effect is generally poor. Radiotherapy is an important part of comprehensive treatment for diffuse gastric cancer, which can reduce tumor stage before surgery and prevent recurrence and metastasis after surgery. Effective neoadjuvant radiotherapy is one of the approaches to improve surgical resection rate in patients with diffuse gastric cancer. In this paper, the clinical application of radiotherapy for diffuse gastric cancer will be reviewed, including the selection of reasonable radiotherapy system, precise location, dose setting, application of sensitization technology and mechanism of sensitization, in addition, the prevention and treatment of neoadjuvant radiotherapy and radiotherapy complications will be introduced.
10.Effects of enteral nutrition powder on short-term postoperative outcomes of patients with digestive tract malignancies in China: a Meta-analysis
Mingwei ZHU ; Hongyuan CUI ; Zijian LI ; Chengyu LIU ; Junmin WEI
Chinese Journal of Digestive Surgery 2021;20(11):1227-1236
Nutritional support therapy can improve to the postoperative nutritional status and quality of life of patients with digestive tract malignancies. Clinical guidelines at home and abroad recommend early preoperative nutritional support therapy based on oral nutrition supple-mentation for patients undergoing surgery for digestive tract malignancies to reduce the risk of malnutrition. Enteral nutrition powder is the main perioperative nutritional support method for patients with basically normal gastrointestinal function. At present, many Meta-analyses also point out that early postoperative nutrition can effectively enhance the body′s immunity, reduce post-operative complications and shorten the length of hospital stay. However, the analysis of short-term outcome indicators is not comprehensive, and there is no summary analysis result on Chinese patients. The authors review the relevant literatures and conduct a Meta-analysis to evaluate the effect of enteral nutrition powder on the short-term postoperative outcomes of Chinese patients with digestive tract malignancies.

Result Analysis
Print
Save
E-mail